InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PSYENCE BIOMEDICAL LTD.

PBM Clue Score59
Ontario, Canada Fiscal year ends March CIK 0001985062
$4.55 -4.01% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.55 +27.81% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 25 Jan 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Net income
Fiscal year 2023Net income−3.2EPS, diluted−394.06Fiscal year 2024Net income−51.2EPS, diluted−4,674.25Fiscal year 2025Net income1.0EPS, diluted5.24
FY2023FY2024FY2025
Net income −3.2 −51.2 1.0
Growth
EPS, diluted −394.06 −4,674.25 5.24

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−1.6Fiscal year 2024Operating cash flow−2.9Capital expenditure−0.0Free cash flow−3.0Fiscal year 2025Operating cash flow−3.7Capital expenditure−0.0Free cash flow−3.7
FY2023FY2024FY2025
Operating cash flow −1.6 −2.9 −3.7
Capital expenditure n/a −0.0 −0.0
Free cash flow n/a −3.0 −3.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2023Cash and securities1.3Shareholders’ equity−0.2Fiscal year 2024Cash and securities0.7Shareholders’ equity−11.0Fiscal year 2025Cash and securities6.1Shareholders’ equity6.7
FY2023FY2024FY2025
Cash and securities 1.3 0.7 6.1
Shareholders’ equity −0.2 −11.0 6.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Mar 2023 FY2024 31 Mar 2024 FY2025† 31 Mar 2025
Assets
1.3 0.7 6.1
n/a 0.0 0.0
1.6 1.1 7.3
Growth −28.8% +546.2%
Liabilities
1.8 12.1 0.6
Equity
−6.3 −57.5 −56.4
−0.2 −11.0 6.7
Growth
Per share and net cash
n/a 13.4 0.6
calc n/a −0.82 11.83

† The number of shares outstanding jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split. This count is a different filed figure from the diluted average on the income statement, so it can break in a different year.

Lines marked calc are worked out here from filed figures; point at one for how.